Heal 30 damage from this Pokémon.
If your opponent's Active Pokémon is a Pokémon ex or Pokémon V, this attack does 100 more damage.
Release year for Paldean Fates is 2024. It belongs to the Scarlet & Violet series.
The checklist contains 245 cards, placing it in a large expansion range. As of 2026, the set is 2 years old and still in a recent release window.
Within this set, Ceruledge is card number 40 with a Rare designation.
Ceruledge is a Paldean Fates card from the 2024 release window. The printed flavor text states: "The fiery blades on its arms burn fiercely with the lingering resentment of a sword wielder who fell before accomplishing their goal." Its card type is Pokémon.
The rarity label is Rare. Printed HP is 140.
Energy typing is Psychic. This gives collectors a clear identity footprint for the print.
This card evolves from Charcadet. The printed attacks highlight "Life Sucker" and "Fighting Sword".
Current market pricing for Ceruledge (Paldean Fates) sits near $0.13. Over the last 7 days it declined 18.8%.
It is currently 20.7% below the 30-day average of $0.16. The 90-day window shows a floor near $0.10 and a peak around $0.19 (69% total spread), which maps to high-volatility movement.
The listed rarity for this print is Rare.
Collectors tracking Ceruledge often benchmark it against other Ceruledge cards. The current sample spans 6 comparable cards from 5 sets.
Comparable prices currently cover $0.09-$17.25, a 19067% band. Against the sample mean of $5.95, this card is -98%.
Notable alternatives include Ceruledge #14 (Mega Evolution Black Star Promos) at $11.03, Ceruledge #20 (Phantasmal Flames) at $0.15, Ceruledge #35 (Surging Sparks) at $0.09, and Ceruledge #197 (Surging Sparks) at $17.25.
Pricing context for collectors: Week-over-week movement is negative (18.8%); this leaves value 32% under the 90-day peak. Observed 90-day bounds of $0.10 and $0.19 create a 69% band, matching a high-volatility profile.
Versus the 30-day average ($0.16), the card is trading 20.7% lower. Top-grade copies show substantial separation from raw: PSA 10 is pricing +66292% above the current raw benchmark.
PSA 9 is currently around $10.03, while PSA 10 is $86.31.
